HR+ Advanced or Metastatic Breast Cancer
2 clinical trials · Condition
◉ Watch HR+ Advanced or Metastatic Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Managed Access Program to Provide Alpelisib for Patients With HR+ Advanced or Metastatic Breast Cancer (NCT03706573) | Novartis Pharmaceuticals |
Track HR+ Advanced or Metastatic Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.